Cleavable vs Non-cleavable ADC Linkers

How this supports a project

Cleavable and non-cleavable are mechanism classes, not a ranking. Selection depends on the exact antibody, target and internalization route, payload, linker-payload structure, conjugation site, drug loading, expected catabolite, and the assays used to verify stability and release.

Define the released species and pathway

A cleavable linker contains a bond or sequence intended to respond to a defined chemical or enzymatic environment. Protease-sensitive peptides, acid-labile groups, reducible disulfides, and other enzyme-responsive motifs are different designs with different stability and release profiles. The trigger, spacer and self-immolative step, payload attachment atom, and resulting released species must be stated for the exact linker-payload.

A non-cleavable linker is not designed to release the payload by breaking the linker itself. Activity generally depends on internalization and lysosomal degradation of the antibody, producing a payload-linker-amino-acid catabolite. That catabolite, rather than the unconjugated payload, must retain the required intracellular activity and transport behavior.

What changes the decision

Circulation and matrix stability

Measure intact ADC, deconjugation, trigger-specific cleavage, payload-related species, aggregation, and loading distribution in the intended species matrix and storage conditions.

Internalization and processing

Define antigen density, internalization and trafficking, lysosomal access, relevant enzymes or chemical trigger, processing rate, and the identity of intracellular catabolites.

Payload and released species

Confirm potency, polarity, charge, permeability, transporter dependence, stability, and activity of the actual released payload or payload-linker-amino-acid catabolite.

Conjugation site and loading

Attachment site, chemistry, average drug-to-antibody ratio, species distribution, and site occupancy can alter stability, clearance, hydrophobicity, aggregation, and exposure.

Spacer and whole-conjugate properties

Assess spacer length and polarity, solubility, hydrophobic interaction, free linker-payload, conjugation conversion, purification recovery, and final ADC concentration behavior.

Bystander hypothesis

Do not infer bystander activity from a cleavable label alone. It depends on where release occurs and whether the released species remains active and can cross membranes and tissue before being cleared or transformed.

Information needed for linker selection

Antibody and target biology

Antibody format, available attachment sites, target density and heterogeneity, internalization, trafficking, lysosomal processing, species models, and intended controls.

Payload definition

Complete structure, attachment atom, mechanism, potency range, physicochemical properties, sensitive groups, expected catabolites, and analytical standards.

Linker-payload hypothesis

Cleavage trigger or stable-linker rationale, spacer, self-immolative group, conjugation handle, expected release product, required stability window, and comparator structures.

Conjugation process

Site and chemistry, reduction or activation conditions, target and distribution of loading, reaction order, quench, purification, free species limits, and material scale.

Analytical and biological plan

Identity, loading and distribution, site occupancy, purity, aggregates, free payload, stability, catabolite or release assay, binding, internalization, cell activity, and matched controls.

Limits of this comparison

CHEMOS can evaluate selected cleavable or non-cleavable linker building blocks, functionalized payload-linker intermediates, conjugation handles, spacers, and defined analog series. These materials do not establish ADC binding, internalization, circulation stability, release, catabolite activity, bystander effect, efficacy, safety, clinical suitability, freedom to operate, or regulatory status. Those conclusions require the exact finished conjugate and an appropriate analytical and biological program.

FAQ

Is a cleavable linker always preferred?

No. Cleavable and non-cleavable designs can both be appropriate. Selection requires the exact released species, target-cell processing, payload properties, conjugation format, stability window, and comparison data.

What is needed to scope a custom ADC linker?

Provide the antibody and attachment site, payload structure and attachment atom, release or catabolite hypothesis, spacer and handle, target loading, stability conditions, analytical methods, and biological controls.

Related catalog and technical pages

ADC linkers and conjugation reagentsBrowse cleavable and stable linkers, hydrophilic spacers, conjugation handles, and related intermediates.ADC linker-payload chemistryReview linker architecture, payload attachment, release definition, conjugation-ready intermediates, and project inputs.ADC development chemistryReview target and antibody inputs, linker-payload selection, conjugation, purification, and final-conjugate controls.Conjugation chemistry and linkersReview attachment sites, reaction sequence, spacer function, purification, and analysis across conjugate formats.Analytical method supportReview identity, loading distribution, free species, aggregates, release, catabolites, and stability methods.